Seetal Dodd

Summary

Affiliation: Barwon Health
Country: Australia

Publications

  1. ncbi The pharmacology of bipolar disorder during pregnancy and breastfeeding
    Seetal Dodd
    Department of Clinical and Biomedical Sciences, University of Melbourne, Community and Mental Health, Barwon Health, Swanston Centre, Geelong, Victoria, Australia
    Expert Opin Drug Saf 3:221-9. 2004
  2. ncbi Putative neuroprotective agents in neuropsychiatric disorders
    Seetal Dodd
    School of Medicine, Deakin University, Geelong, Victoria, Australia Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    Prog Neuropsychopharmacol Biol Psychiatry 42:135-45. 2013
  3. ncbi The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium
    Seetal Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Australia
    Curr Drug Saf 1:25-33. 2006
  4. ncbi Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility
    Seetal Dodd
    Department of Clinical and Biomedical Sciences, University of Melbourne, Geelong, Australia
    Expert Rev Neurother 8:1299-306. 2008
  5. ncbi N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
    Seetal Dodd
    University of Melbourne, Department of Clinical and Biomedical Sciences, Barwon Health, PO Box 281, Geelong 3220, Victoria, Australia
    Expert Opin Biol Ther 8:1955-62. 2008
  6. ncbi Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample
    Seetal Dodd
    University of Melbourne, Department of Clinical and Biomedical Sciences, Barwon Health, Geelong, Vic, Australia
    Aust N Z J Psychiatry 43:526-30. 2009
  7. ncbi To combine or not to combine? A literature review of antidepressant combination therapy
    Seetal Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Swanston Centre, PO Box 281, Geelong 3220, Victoria, Australia
    J Affect Disord 89:1-11. 2005
  8. ncbi Clinical characteristics and management of bipolar disorder in women across the life span
    Seetal Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Swanston Centre, PO Box 281, Geelong 3220, Australia
    Womens Health (Lond Engl) 1:421-8. 2005
  9. ncbi A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder
    S Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, The University of Melbourne, Geelong, Victoria, Australia
    J Affect Disord 124:22-8. 2010
  10. ncbi Evidence and implications for early intervention in bipolar disorder
    Michael Berk
    Department of Clinical and Biomedical Sciences, University of Melbourne, Parkville, Australia
    J Ment Health 19:113-26. 2010

Detail Information

Publications72

  1. ncbi The pharmacology of bipolar disorder during pregnancy and breastfeeding
    Seetal Dodd
    Department of Clinical and Biomedical Sciences, University of Melbourne, Community and Mental Health, Barwon Health, Swanston Centre, Geelong, Victoria, Australia
    Expert Opin Drug Saf 3:221-9. 2004
    ..Ideally, a treatment regimen tailored to suit the individual should consider both mother and baby and should be planned prior to conception...
  2. ncbi Putative neuroprotective agents in neuropsychiatric disorders
    Seetal Dodd
    School of Medicine, Deakin University, Geelong, Victoria, Australia Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    Prog Neuropsychopharmacol Biol Psychiatry 42:135-45. 2013
    ..These agents are putative neuroprotective agents for schizophrenia and mood disorders...
  3. ncbi The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperium
    Seetal Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Australia
    Curr Drug Saf 1:25-33. 2006
    ..Adverse outcomes from inadequate pharmacological prophylaxis have been documented for both the mother and the baby. Risks and benefits need to be carefully balanced based on an accurate review of the evidence...
  4. ncbi Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility
    Seetal Dodd
    Department of Clinical and Biomedical Sciences, University of Melbourne, Geelong, Australia
    Expert Rev Neurother 8:1299-306. 2008
    ..Treatment decisions therefore need to be made to balance the risks and benefits...
  5. ncbi N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
    Seetal Dodd
    University of Melbourne, Department of Clinical and Biomedical Sciences, Barwon Health, PO Box 281, Geelong 3220, Victoria, Australia
    Expert Opin Biol Ther 8:1955-62. 2008
    ..Treatment with N-acetylcysteine (NAC) has been shown to increase levels of glutathione. NAC has been proposed as a treatment for several illnesses...
  6. ncbi Reliability of the Mood Disorder Questionnaire: comparison with the Structured Clinical Interview for the DSM-IV-TR in a population sample
    Seetal Dodd
    University of Melbourne, Department of Clinical and Biomedical Sciences, Barwon Health, Geelong, Vic, Australia
    Aust N Z J Psychiatry 43:526-30. 2009
    ..The aim of the present study was therefore to investigate the reliability of this instrument...
  7. ncbi To combine or not to combine? A literature review of antidepressant combination therapy
    Seetal Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Swanston Centre, PO Box 281, Geelong 3220, Victoria, Australia
    J Affect Disord 89:1-11. 2005
    ..This paper reviews published trials on combination antidepressants with a view to inform clinical practice...
  8. ncbi Clinical characteristics and management of bipolar disorder in women across the life span
    Seetal Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Swanston Centre, PO Box 281, Geelong 3220, Australia
    Womens Health (Lond Engl) 1:421-8. 2005
    ..Special consideration is required for the treatment of bipolar disorder during reproductive events. More studies are required to better understand the course, outcome and gender-specific treatment strategies of this disorder...
  9. ncbi A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder
    S Dodd
    Department of Clinical and Biomedical Sciences Barwon Health, The University of Melbourne, Geelong, Victoria, Australia
    J Affect Disord 124:22-8. 2010
    ..This study investigated the clinical outcomes in participants with bipolar I disorder or schizoaffective disorder, using the Cassidy and Benazzi criteria for manic and depressive mixed states, respectively...
  10. ncbi Evidence and implications for early intervention in bipolar disorder
    Michael Berk
    Department of Clinical and Biomedical Sciences, University of Melbourne, Parkville, Australia
    J Ment Health 19:113-26. 2010
    ..To review the evidence that supports early intervention in the treatment of bipolar disorder...
  11. ncbi Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial
    Michael Berk
    Deakin University, School of Medicine, Barwon Health, P O Box 291, Geelong, 3220, Australia
    BMC Med 10:91. 2012
    ..The current study aimed to investigate the maintenance effects of NAC following eight weeks of open-label treatment for bipolar disorder...
  12. ncbi Lifetime psychiatric disorders and body composition: a population-based study
    Lana J Williams
    Department of Clinical and Biomedical Sciences Barwon Health, The University of Melbourne, PO Box 281, Geelong 3220, Australia
    J Affect Disord 118:173-9. 2009
    ..This study aimed to investigate the relationship between depressive and anxiety disorders and indices of adiposity, including body fat mass and percent body fat, as measured by dual energy X-ray absorptiometry...
  13. ncbi Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention
    Michael Berk
    School of Medicine, Deakin University, Geelong, Victoria 3220, Australia
    Bipolar Disord 13:87-98. 2011
    ..The staging model suggests that early stages of bipolar disorder respond better to treatments and have a more favourable prognosis. This study aims to provide empirical support for the model, and the allied construct of early intervention...
  14. ncbi The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial
    Michael Berk
    Department of Psychiatry, The University of Melbourne, Parkville, Australia
    J Affect Disord 135:389-94. 2011
    ..Given the failure of almost all modern trials of antidepressants in bipolar disorder to demonstrate efficacy, and the limited efficacy of mood stabilisers in the depressive phase of the disorder, this is a major unmet need...
  15. ncbi Psychometric properties of a scale to measure investment in the sick role: the Illness Cognitions Scale
    Michael Berk
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Victoria, Australia
    J Eval Clin Pract 18:360-4. 2012
    ..We describe the psychometric properties of a new scale, the Illness Cognitions Scale (ICS), a metric of investment in the sick role...
  16. ncbi Annual high-dose vitamin D3 and mental well-being: randomised controlled trial
    Kerrie M Sanders
    Department of Clinical and Biomedical Sciences, Barwon Health, PO Box 281, Geelong, Victoria, Australia 3220
    Br J Psychiatry 198:357-64. 2011
    ..Epidemiological evidence supports a relationship between vitamin D and mental well-being, although evidence from large-scale placebo-controlled intervention trials is lacking...
  17. ncbi From neuroprogression to neuroprotection: implications for clinical care
    Michael Berk
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Melbourne, Vic
    Med J Aust 193:S36-40. 2010
    ..These developments need to be combined with service initiatives to maximise the opportunities for early diagnosis and intervention...
  18. ncbi Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample
    Michael Berk
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Australia
    Aust N Z J Psychiatry 42:874-8. 2008
    ..The aim of the present study was to investigate the relationship between reduced serum vitamin D levels and psychiatric illness...
  19. ncbi Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression
    Lana J Williams
    Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, Geelong, Victoria, Australia
    Int Clin Psychopharmacol 23:84-7. 2008
    ..03) than nonusers. No differences in BMD were detected at other sites. Although the mechanism remains unclear, these observations are consistent with a role for the serotonergic system in regulating bone metabolism...
  20. ncbi The sick role, illness cognitions and outcomes in bipolar disorder
    Michael Berk
    School of Medicine, Deakin University, Geelong, VIC 3220, Australia
    J Affect Disord 146:146-9. 2013
    ..We conducted analyses to test the hypothesis that there may be an association between illness cognitions and clinical and functional measures...
  21. ncbi Setting the stage: from prodrome to treatment resistance in bipolar disorder
    Michael Berk
    Barwon Health and The Geelong Clinic, Geelong, Victoria, Australia
    Bipolar Disord 9:671-8. 2007
    ..At the other end of the spectrum, the model attempts to operationalize treatment resistance. The utility of the model will need to be validated by empirical research...
  22. ncbi Monitoring the safe use of clozapine: a consensus view from Victoria, Australia
    Michael Berk
    Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, Geelong, Melbourne, Victoria, Australia
    CNS Drugs 21:117-27. 2007
    ....
  23. ncbi A descriptive interview with 64 patients discharged from an acute-psychiatric-inpatient service
    Tom Callaly
    Community and Mental Health, Barwon Health, Swanston Centre, Geelong, Victoria, Australia
    J Eval Clin Pract 14:990-5. 2008
    ..This study compares the findings of comprehensive interviews conducted with current and past patients of the community mental-health service 3 or more years following case closure from the community ambulatory service...
  24. ncbi Depression and bone metabolism. A review
    Lana J Williams
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, VIC Australia
    Psychother Psychosom 78:16-25. 2009
    ..This paper aims to review the current evidence on the relationship between depression and bone mineral density, and identify potential mechanisms...
  25. ncbi Vitamin D deficiency may play a role in depression
    Michael Berk
    The University of Melbourne, Department of Clinical and Biomedical Sciences, PO Box 281, Geelong 3220, Victoria, Australia
    Med Hypotheses 69:1316-9. 2007
    ..There are a number of trials that have suggested a role for Vitamin D in the supplementary treatment of depression. Dose may be a critical issue, as sun exposure and dietary intake may be low and high doses may be required...
  26. ncbi The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use
    Michael Berk
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
    J Eval Clin Pract 14:979-83. 2008
    ..The Clinical Global Impression Scale (CGI) is established as a core metric in psychiatric research. This study aims to test the validity of CGI as a clinical outcome measure suitable for routine use in a private inpatient setting...
  27. ncbi The prevalence of mood and anxiety disorders in Australian women
    Lana Williams
    Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, Geelong, Vic, Australia
    Australas Psychiatry 18:250-5. 2010
    ..We aimed to report the prevalence, age-of-onset and comorbidity of mood and anxiety disorders in an age-stratified representative sample of Australian women aged 20 years and over...
  28. ncbi Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania
    Michael Berk
    University of Melbourne, Victoria, Australia
    J Affect Disord 110:126-34. 2008
    ..This study aimed to compare the treatment responses between smokers and non-smokers in bipolar mania clinical trials...
  29. ncbi A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder
    Seetal Dodd
    Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, PO Box 281, Geelong VIC 3220, Australia
    Compr Psychiatry 51:504-9. 2010
    ..The impact of tobacco smoking on mental health outcomes was investigated in a 24-month, naturalistic, longitudinal study of 240 people with bipolar disorder or schizoaffective disorder...
  30. ncbi Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice
    Jayashri Kulkarni
    Monash Alfred Psychiatry Research Centre, The Alfred Hospital and Monash University, Central Clinical School, 607 St Kilda Rd, Melbourne, Vic, 3004, Australia
    BMC Psychiatry 12:228. 2012
    ..All participants received treatment as usual. There was no study medication...
  31. ncbi Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting
    Michael Berk
    Department of Clinical and Biomedical Sciences, University of Melbourne, Australia
    CNS Spectr 14:357-60. 2009
    ..Its actions, if robustly replicated, also point to potential treatment targets in glutathione or glutamate pathways in the brain...
  32. ncbi Readmission to an acute psychiatric unit within 28 days of discharge: identifying those at risk
    Thomas Callaly
    Mental Health, Drugs and Alcohol Services, Swanston Centre, Barwon Health, Geelong, VIC 3220, Australia
    Aust Health Rev 34:282-5. 2010
    ..To examine factors that could help identify those most at risk of readmission to an acute psychiatric in-patient unit within 28 days of a discharge...
  33. ncbi 'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states
    Michael Berk
    Barwon Health and The Geewong Clinic, Swanston Centre, PO Box 281, Geelong, Victoria 3220, Australia
    Aust N Z J Psychiatry 39:215-21. 2005
    ..To explore diagnostic and treatment issues concerning bipolar mixed states...
  34. ncbi Pain and the relationship with mood and anxiety disorders and psychological symptoms
    Lana J Williams
    Deakin University, School of Medicine, Geelong, Australia
    J Psychosom Res 72:452-6. 2012
    ..The objective of this study was to investigate the association between pain and mood and anxiety disorders, as well as psychological symptoms, in a population-based sample of women...
  35. ncbi Health-related quality of life and functioning in bipolar disorder: the impact of pharmacotherapy
    Michael Berk
    Professor, University of Melbourne and Orygen Youth Health, Melbourne, Victoria, Australia, Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Victoria 3220, Australia
    Expert Rev Pharmacoecon Outcomes Res 6:509-23. 2006
    ....
  36. ncbi Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
    Michael Berk
    Department of Clinical and Biomedical Sciences, Swanston Centre Barwon Health, University of Melbourne, PO Box 281, Geelong, VIC 3220, Australia
    Med Hypotheses 65:39-43. 2005
    ..A more plausible explanation is that incipient bipolar disorder is often not diagnosed early in children and adolescents and the differential effects of antidepressants in this group is a result of differing diagnostic casemixes...
  37. ncbi Bipolar II disorder: a review
    Michael Berk
    Department of Clinical and Biomedical Sciences, University of Melbourne, Swanston Centre, Geelong, Victoria, Australia
    Bipolar Disord 7:11-21. 2005
    ..To review the current knowledge of bipolar II disorder...
  38. ncbi The management of bipolar disorder in primary care: a review of existing and emerging therapies
    Michael Berk
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
    Psychiatry Clin Neurosci 59:229-39. 2005
    ..This paper will attempt to review existing and emerging therapies in bipolar disorder, as well as their common drug interactions and side-effects...
  39. ncbi Efficacy of atypical antipsychotics in bipolar disorder
    Michael Berk
    Department of Clinical and Biomedical Sciences, The University of Melbourne, Swanston Centre, PO Box 281, Geelong, VIC 3220, Australia
    Drugs 65:257-69. 2005
    ..A number of trials are underway that will hopefully address many of the questions still pending...
  40. ncbi Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives
    Michael Berk
    Department of Clinical and Biomedical Sciences, University of Melbourne, PO Box 281, Geelong, Australia
    J Affect Disord 114:1-13. 2009
    ....
  41. ncbi The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program
    Kristi Ann Villagonzalo
    Department of Clinical and Biomedical Sciences, University of Melbourne, PO Box 281, Geelong, Victoria 3220, Australia
    Compr Psychiatry 52:562-6. 2011
    ..This study explores the relationship between substance abuse and PTSD symptom clusters in a methadone maintenance population...
  42. ncbi Development of guidelines for caregivers of people with bipolar disorder: a Delphi expert consensus study
    Lesley Berk
    Orygen Youth Health Research Centre, Centre for Youth Mental Health Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
    Bipolar Disord 13:556-70. 2011
    ..This study aimed to develop guidelines to assist caregivers of adults with bipolar disorder to be informed about bipolar disorder and to support the person without neglecting their own wellbeing...
  43. ncbi A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
    Seetal Dodd
    School of Medicine, Deakin University, Geelong, Victoria, Australia
    Aust N Z J Psychiatry 45:712-25. 2011
    ..This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring...
  44. ncbi The role of psychotherapy in bipolar disorder
    Sue D Lauder
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Vic, Australia
    Med J Aust 193:S31-5. 2010
    ..Evidence to date supports the use of adjunctive psychosocial interventions in the management of bipolar disorder...
  45. ncbi Oxidative pathways as a drug target for the treatment of autism
    Kristi Ann Villagonzalo
    University of Melbourne, Department of Clinical and Biomedical Sciences, Victoria 3220, Australia
    Expert Opin Ther Targets 14:1301-10. 2010
    ..Current pharmacological treatment options for autism are often focused on addressing comorbid behavioural problems, rather than core features of the disorder. Investigation of a new treatment approach is needed...
  46. ncbi Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder
    Michael Berk
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Swanston Centre, VIC 3220, Australia
    Psychiatry Clin Neurosci 64:367-71. 2010
    ..This approach has the potential to capture a broader, more fine-grained and clinically relevant picture of the process of aggravation of the bipolar cycle...
  47. ncbi Recent developments in the treatment of bipolar disorders
    Michael Berk
    Clinical and Biomedical Sciences, University of Melbourne, Community and Mental Health, Barwon Health, Swanton Centre, PO Box 281, Geelong, Victoria 3220, Australia
    Expert Opin Investig Drugs 12:1621-32. 2003
    ..A growing range of novel therapeutic options for the treatment of bipolar disorder is under investigation. This paper summarises some of the data regarding these potential therapeutic options...
  48. ncbi Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study
    Felice N Jacka
    University of Melbourne, Department of Clinical and Biomedical Sciences, Barwon Health, PO Box 281, Geelong 3220, Victoria, Australia
    Menopause 12:88-91. 2005
    ..This study investigated the association between self-reported depression and BMD in an age-stratified community sample of perimenopausal women residing in the South-Eastern region of Australia...
  49. ncbi Combination pharmacotherapy in unipolar depression
    Felicity Ng
    University of Melbourne, Department of Clinical and Biomedical Sciences Barwon Health, PO Box 281, Geelong, Victoria, Australia
    Expert Rev Neurother 6:1049-60. 2006
    ..This paper reviews the current evidence for combination pharmacotherapy in unipolar depression and discusses its clinical applications...
  50. ncbi Effects of a walking program in the psychiatric in-patient treatment setting: a cohort study
    Felicity Ng
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Victoria, Australia
    Health Promot J Austr 18:39-42. 2007
    ..To assess the effectiveness of a walking program in a psychiatric in-patient unit...
  51. ncbi Client-reported reasons for non-engagement in drug and alcohol treatment
    Carolyn Coulson
    Department of Clinical and Biomedical Sciences, Barwon Health, The University of Melbourne, Geelong, Australia
    Drug Alcohol Rev 28:372-8. 2009
    ..To examine client-reported reasons for missed early appointments at a drug and alcohol treatment service and to compare characteristics of those who missed appointments with those who attended...
  52. ncbi Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial
    Michael Berk
    Department of Clinical and Biomedical Sciences Barwon Health, The University of Melbourne, Geelong, Australia
    Hum Psychopharmacol 24:233-8. 2009
    ..This study investigates the efficacy of adding mirtazapine to treatment as usual to alleviate the negative symptoms of schizophrenia...
  53. ncbi A qualitative evaluation of a regional Early Psychosis Service 3 years after its commencement
    Thomas Callaly
    School of Medicine, Deakin University, Geelong, VIC 3220, Australia
    Aust Health Rev 34:382-5. 2010
    ..To outline the major findings of a qualitative evaluation of an Early Psychosis Service 3 years after its establishment...
  54. ncbi Diagnosing bipolar disorder: how can we do it better?
    Michael Berk
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Vic, Australia
    Med J Aust 184:459-62. 2006
    ..There is a risk of over-diagnosis of bipolar disorder among patients who are histrionic, show abnormal illness behaviour and/or have issues of secondary gain...
  55. ncbi The effect of macroeconomic variables on suicide
    Michael Berk
    Department of Clinical and Biomedical Sciences - Barwon Health, University of Melbourne, Geelong, Victoria, Australia
    Psychol Med 36:181-9. 2006
    ..CONCLUSION: Macroeconomic trends are significantly associated with suicide. The patterns in males and females are very different, and there are further substantial age-related differences...
  56. ncbi Glutathione: a novel treatment target in psychiatry
    Michael Berk
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
    Trends Pharmacol Sci 29:346-51. 2008
    ..This article outlines the multidimensional evidence that currently exists for oxidative stress mechanisms in psychiatric disorders and specifically discusses glutathione as a promising novel therapeutic target...
  57. ncbi Do ambient electromagnetic fields affect behaviour? A demonstration of the relationship between geomagnetic storm activity and suicide
    Michael Berk
    Department of Clinical and Biomedical Sciences Barwon Health, University of Melbourne, Geelong, Australia
    Bioelectromagnetics 27:151-5. 2006
    ..The study furthermore raises issues regarding other sources of stray electromagnetic fields and their effect on mental health...
  58. ncbi Depression and mania in mixed states
    Michael Berk
    University of Melbourne, Clinical and Biomedical Sciences-Barwon Health, P.O. Box 281, Geelong, Victoria, Australia
    Am J Psychiatry 163:1160. 2006
  59. ncbi 'Mind and Body': a lifestyle programme for people on antipsychotic medication
    Amanda Jones
    Barwon Health, Community and Mental Health, Torquay, Victoria, Australia
    J Eval Clin Pract 15:276-80. 2009
    ..Psychiatric illnesses such as schizophrenia and their treatments have consequences in terms of lifestyle, diet and weight...
  60. ncbi Combination antidepressants - use by GPs and psychiatrists
    David Horgan
    Department of Psychiatry, University of Melbourne, Victoria, Australia
    Aust Fam Physician 40:397-400. 2011
    ..Current treatment of depression fails to achieve remission in 50% of patients. Combinations of two antidepressants are used by some Australian psychiatrists...
  61. ncbi The effects of physical activity in the acute treatment of bipolar disorder: a pilot study
    Felicity Ng
    Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong, Victoria, Australia
    J Affect Disord 101:259-62. 2007
    ..This study is a pilot investigation into the effectiveness of an adjunctive walking program in the acute treatment of bipolar disorder...
  62. ncbi A review of clozapine safety
    Joanna Fitzsimons
    Department of Clinical and Biomedical Sciences, Barwon Health, Swanston Centre, University of Melbourne, PO Box 281, Geelong, Victoria 3220, Australia
    Expert Opin Drug Saf 4:731-44. 2005
    ..Understanding the safety profile of clozapine allows an informed use of the agent that can maximise its clear clinical benefit and minimise the known risks...
  63. ncbi An audit of clinical outcomes and client and referrer satisfaction with a Mood and Anxiety Disorders Unit
    Raylene Lewis
    Clinical and Biomedical Sciences, University of Melbourne, Community and Mental Health, Barwon Health, Swanston Centre, Geelong, Victoria, Australia
    J Eval Clin Pract 10:549-52. 2004
    ..In comparison the mean PGI rat-ing at the time of follow-up was 6.64 (SD=1.91). CONCLUSIONS: Specialist mood disorders units are a useful and potentially cost-effective additional service included as a part of a mental health service...
  64. ncbi Lamotrigine in epilepsy, pregnancy and psychiatry--a drug for all seasons?
    Frank J E Vajda
    Department of Neuroscience, University of Melbourne, Royal Melbourne Hospital, Grattan Street, Parkville 3050, Victoria, Australia
    J Clin Neurosci 20:13-6. 2013
    ..It has a more benign adverse effect profile than older antiepileptic agents and is not a proven teratogen. Risk of adverse reactions is reduced by commencing treatment at a markedly reduced dose that is gradually increased...
  65. ncbi Trichotillomania: response to lithium in a person with comorbid bipolar disorder
    Michael Berk
    Hum Psychopharmacol 18:576-7. 2003
  66. ncbi A survey of combination antidepressant use in Australia
    David Horgan
    Australas Psychiatry 15:26-9. 2007
    ..The aim of this study was to survey doctors working in psychiatry in Australia about the practice of using two antidepressants simultaneously...
  67. ncbi Antidepressants and adolescents: the bipolar confound?
    Michael Berk
    Hum Psychopharmacol 20:1-2. 2005
  68. ncbi Diagnosis and management of patients with bipolar disorder in primary care
    Michael Berk
    Br J Gen Pract 55:663-6. 2005
  69. ncbi The Bipolar Comprehensive Outcomes Study (BCOS): baseline findings of an Australian cohort study
    Jayashri Kulkarni
    Alfred Psychiatry Research Centre, The Alfred and Monash University, School of Psychology, Psychiatry and Psychological Medicine, Commercial Road, Melbourne VIC 3004, Australia
    J Affect Disord 107:135-44. 2008
    ..The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, observational study of participants with bipolar I or schizoaffective disorder examining clinical, functional, and economic outcomes associated with naturalistic treatment...
  70. ncbi A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use
    Sean Jespersen
    Department of Psychiatry, University of Witwatersrand Medical School, Parktown, South Africa
    Int Clin Psychopharmacol 19:161-4. 2004
    ..No statistical differences were measured at baseline or at endpoint between the granisetron or placebo group. This study did not produce evidence supporting the usefulness of granisetron in AISD...
  71. ncbi Identification of a by-product of nitric oxide synthase activity in human acute brain injury with in vivo proton magnetic resonance spectroscopy
    Morry Silberstein
    Department of Radiology, University of Sydney, School of Medicine, Monash University, Australia
    AJNR Am J Neuroradiol 23:389-92. 2002
    ..Confirmation with the acquisition of spectra in very early acute cerebral injury would provide a rationale for the use of neuroprotective agents in these conditions, as well as a new noninvasive method for quantification...
  72. ncbi Antidepressants and the placebo response
    Michael Berk
    Hum Psychopharmacol 20:305-7. 2005